Moderna vaccine more effective than Pfizer, study says
Moderna’s Covid-19 vaccine does a slightly better job of preventing coronavirus-related hospitalizations and emergency department visits.
Swedish drugmaker SOBI soars on $8 billion takeover bid from U.S. private equity
Swedish drugmaker Orphan Biovitrum (SOBI) has agreed to an $8 billion takeover bid from US private equity firm Advent International Singapore’s sovereign wealth fund GIC.
Bain Capital gives up majority stake in South Korea Botox Company for $1.5 billion
South Korea’s biggest producer of botulinum toxin, Hugel is concerned about its expansion now as Botox Company is sold.
Bayer snaps up biotech firm Vividion Therapeutics for $2 billion
Bayer AG is in talks to buy Vividion Therapeutics in a roughly $2 billion deal, enforcing new IPO plans for Vividion.
Sanofi bets big on mRNA future with Translate Bio acquisition offer
Sanofi’s CEO Paul Hudson is dead serious about mRNA technology and capabilities with a $3.2 billion acquisition offer to Translate Bio.
Tokyo Games organizing Committee head says cancellation of Olympics 2020 quite possible
Tokyo Olympic Games 2021 face cancellation threat due to the rising number of Covid-19 cases, says organizing committee head.
Johnson & Johnson recalls sunscreen products due to benzene traces
Johnson & Johnson (J&J) announced Wednesday it is recalling five of its sunscreen products after some samples were found to contain low levels of Benzene, a chemical that c
Corona variants and inequitable vaccine distribution worrying, say G20 nations
The rise in new variants of the Coronavirus and poor access to vaccines in developing countries will derail the recovery of economies across the world, warn the finance ministers o
Flagship Pioneering, investor in Moderna raises $3.4 billion funds
Flagship Pioneering, the bioplatform company, and the venture capital investor in Moderna, today announced that it had raised additional funding of $2.23 billion, which brings its
